pLenti-CMV-Blast-PIP-FUCCI Citations (6)

Originally described in: Accurate delineation of cell cycle phase transitions in living cells with PIP-FUCCI.
Grant GD, Kedziora KM, Limas JC, Cook JG, Purvis JE Cell Cycle. 2018;17(21-22):2496-2516. doi: 10.1080/15384101.2018.1547001. PubMed Journal

---

Articles Citing pLenti-CMV-Blast-PIP-FUCCI

Articles
Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer. Sela Y, Li J, Maheswaran S, Norgard R, Yuan S, Hubbi M, Doepner M, Xu JP, Ho ES, Mesaros C, Sheehan C, Croley G, Muir A, Blair IA, Shalem O, Dang CV, Stanger BZ. Cancer Res. 2022 May 16;82(10):1890-1908. doi: 10.1158/0008-5472.CAN-22-0431. PubMed
EPIKOL, a chromatin-focused CRISPR/Cas9-based screening platform, to identify cancer-specific epigenetic vulnerabilities. Yedier-Bayram O, Gokbayrak B, Kayabolen A, Aksu AC, Cavga AD, Cingoz A, Kala EY, Karabiyik G, Gunsay R, Esin B, Morova T, Uyulur F, Syed H, Philpott M, Cribbs AP, Kung SHY, Lack NA, Onder TT, Bagci-Onder T. Cell Death Dis. 2022 Aug 16;13(8):710. doi: 10.1038/s41419-022-05146-4. PubMed
Nucleotide depletion promotes cell fate transitions by inducing DNA replication stress. Do BT, Hsu PP, Vermeulen SY, Wang Z, Hirz T, Abbott KL, Aziz N, Replogle JM, Bjelosevic S, Paolino J, Nelson SA, Block S, Darnell AM, Ferreira R, Zhang H, Milosevic J, Schmidt DR, Chidley C, Harris IS, Weissman JS, Pikman Y, Stegmaier K, Cheloufi S, Su XA, Sykes DB, Vander Heiden MG. Dev Cell. 2024 May 30:S1534-5807(24)00327-7. doi: 10.1016/j.devcel.2024.05.010. PubMed
LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast Cancer. Zhang Q, Wang X, Shao Z, Zhang Y, Zhang L, Chen M, Zhou X, Zhu H, Zhou Y, Lu X, Li P, Chi W, Li L, Shao ZM, Huang S, Xue J, Chi Y, Wu J, Xiu B. Adv Sci (Weinh). 2025 Apr;12(14):e2413527. doi: 10.1002/advs.202413527. Epub 2025 Feb 14. PubMed
Multimodal Nanoplasmonic and Fluorescence Imaging for Simultaneous Monitoring of Single-Cell Secretory and Intracellular Dynamics. Ansaryan S, Chiang YC, Liu YC, Reichenbach P, Irving M, Altug H. Adv Sci (Weinh). 2025 Apr;12(16):e2415808. doi: 10.1002/advs.202415808. Epub 2025 Mar 5. PubMed
Piperazine-Substituted Pyranopyridines Exhibit Antiproliferative Activity and Act as Inhibitors of HBV Virion Production. Buloyan S, Harutyunyan A, Gasparyan H, Sakeyan A, Shahkhatuni A, Zakirova NF, Yusubalieva G, Kirillov IM, Fedyakina IT, Solyev PN, Lipatova AV, Bogomolov MA, Prassolov VS, Lebedev TD, Ivanov AV. Int J Mol Sci. 2025 Apr 23;26(9):3991. doi: 10.3390/ijms26093991. PubMed

If you have published an article using this material, please email us at to have your article added to this page.